Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Akiko, Nagatani"'
Autor:
Tomiko Sunaga, Touji Hashimoto, Toru Watanabe, Tadanori Sasaki, Naokazu Fujii, Akiko Nagatani
Publikováno v:
Cancer Reports
Background Quality of life can be influenced by oral mucositis (OM), and it is necessary to implement OM management strategies before the initiation of radiotherapy (RT) in patients with head and neck cancer (HNC). Aims To examine the association bet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::665019176f9efcfa02546064c665a068
http://europepmc.org/articles/PMC8451373
http://europepmc.org/articles/PMC8451373
Autor:
Tadanori Sasaki, Toru Watanabe, Motoki Yamagishi, Haruaki Sasaki, Noriko Takahashi, Akiko Nagatani, Tomiko Sunaga, Tatsuhiro Fujimiya, Tatsuya Kurihara, Yoshio Ogawa
Publikováno v:
Chemotherapy. 65(1-2)
Introduction: Combination chemotherapy of gemcitabine and cisplatin (GC) is the standard treatment for patients with urothelial cancer (UC). However, hematological toxicity is a major side effect of GC therapy in patients with UC. In particular, disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f2e7149badef5734b21bef51557ff34
https://pubmed.ncbi.nlm.nih.gov/32668429
https://pubmed.ncbi.nlm.nih.gov/32668429
Autor:
Yumiko Ogawa, Tomiko Sunaga, Masahiro Usuda, Kazuki Tomura, Tadanori Sasaki, Yuki Naito, Hiroyuki Sakamaki, Akiko Nagatani, Nao Akiyama, Mari Kogo, Tatsuya Kurihara, Haruaki Sasaki, Tatsunori Murata
Publikováno v:
YAKUGAKU ZASSHI. 138:1397-1407
Sunitinib has been shown to offer clinical benefits during the treatment of advanced renal cell carcinoma. However, molecular targeting drugs are expensive and can have a significant impact on medical expenses. The purpose of this study was to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4df8437356e8575c0fd3877059a6f04
https://doi.org/10.1248/yakushi.17-00189
https://doi.org/10.1248/yakushi.17-00189
Autor:
Kazuki, Tomura, Yuki, Naito, Tomiko, Sunaga, Tatsuya, Kurihara, Masahiro, Usuda, Akiko, Nagatani, Yumiko, Ogawa, Nao, Akiyama, Haruaki, Sasaki, Tatsunori, Murata, Hiroyuki, Sakamaki, Mari, Kogo, Tadanori, Sasaki
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 138(11)
Sunitinib has been shown to offer clinical benefits during the treatment of advanced renal cell carcinoma. However, molecular targeting drugs are expensive and can have a significant impact on medical expenses. The purpose of this study was to assess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5564d325c0d85e60fdf6a69019b4ca31
https://pubmed.ncbi.nlm.nih.gov/30381648
https://pubmed.ncbi.nlm.nih.gov/30381648
Autor:
Kazuki Tomura, Yuki Naito, Mari Kogo, Naokazu Fujii, Akiko Nagatani, Touji Hashimoto, Yumiko Ogawa, Tadanori Sasaki, Tomiko Sunaga, Takayuki Okabe
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 137(2)
Radiotherapy (RT) and chemoradiotherapy (CRT) is widely accepted as the standard treatment for head and neck cancer (HNC). Oral mucositis (OM) often develops as an adverse reaction in HNC patients that receive RT or CRT involving S-1. However, little
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e1a4b26c7513635a6dfc1496558449
https://pubmed.ncbi.nlm.nih.gov/28154335
https://pubmed.ncbi.nlm.nih.gov/28154335
Autor:
Mari Kogo, Noriko Takahashi, Tadanori Sasaki, Mayumi Higashino, Mitsuki Matsui, Fumio Kokubu, Tomiko Sunaga, Tomomi Hozumi, Shoko Nakamura, Akiko Nagatani, Kazushi Shimamoto
Publikováno v:
Chemotherapy. 62(6)
Zoledronic acid is an established agent used in the management of metastatic bone disease. The administration of zoledronic acid improves overall survival (OS) of lung cancer patients with bone metastases receiving chemotherapy. However, it is curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::371dc12ba928f4e8e39b2a60edc5fa32
https://pubmed.ncbi.nlm.nih.gov/28605733
https://pubmed.ncbi.nlm.nih.gov/28605733